Basic Information
| RNALocate ID: | RLID:01001852 |
| RNA Symbol: | hsa-miR-188-5p |
| Localization: | Nucleus |
RNA Information
| RNA Name: | hsa-miR-188 |
| RNA ID: | miRBase:MIMAT0000457 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001850 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001851 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001853 | Nucleolus | Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001963 | Exosome | Pulmonary epithelial cell line (BEAS-2B) | 31520698 |
| RLID:11001964 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001965 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11001966 | Exosome | Brain tissue | 23382797 |
| RLID:11001967 | Exosome | Plasma | 23663360 |
| RLID-D:11000385 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001183 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-188-5p | Splenic marginal zone lymphoma | MNDR-E-MI-21437 |
| MNDR | hsa-miR-188-5p | B cell lymphoma of malt type | MNDR-E-MI-21438 |
| MNDR | hsa-miR-188-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-21439 |
| MNDR | hsa-miR-188-5p | Ovarian clear cell carcinoma | MNDR-E-MI-21440 |
| MNDR | hsa-miR-188-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-21441 |
| MNDR | hsa-miR-188-5p | Lymphoma | MNDR-E-MI-21442 |
| MNDR | hsa-miR-188-5p | Lymphoma non-hodgkin | MNDR-E-MI-21443 |
| MNDR | hsa-miR-188-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-21444 |
| MNDR | hsa-miR-188-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-21445 |
| MNDR | hsa-miR-188-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-21446 |
| MNDR | hsa-miR-188-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-21447 |
| MNDR | hsa-miR-188-5p | Her2-receptor positive breast cancer | MNDR-E-MI-21448 |
| MNDR | hsa-miR-188-5p | Breast cancer luminal | MNDR-E-MI-21449 |
| MNDR | hsa-miR-188-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-21450 |
| MNDR | hsa-miR-188-5p | Prostate cancer | MNDR-E-MI-21451 |
| MNDR | hsa-miR-188-5p | Chronic lymphocytic leukemia | MNDR-E-MI-21452 |
| MNDR | hsa-miR-188-5p | Gastric cancer | MNDR-E-MI-21453 |
| MNDR | hsa-miR-188-5p | Gastric lymphoma | MNDR-E-MI-21454 |
| MNDR | hsa-miR-188-5p | Alzheimer disease | MNDR-E-MI-21455 |
| MNDR | hsa-miR-188-5p | Intracranial aneurysm | MNDR-E-MI-21456 |
| MNDR | hsa-miR-188-5p | Head and neck cancer | MNDR-E-MI-21457 |
| MNDR | hsa-miR-188-5p | Dengue disease | MNDR-E-MI-21458 |
| MNDR | hsa-miR-188-5p | Lung cancer | MNDR-E-MI-21459 |
| MNDR | hsa-miR-188-5p | Parkinson disease | MNDR-E-MI-21460 |
| MNDR | hsa-miR-188-5p | Basal-like breast cancer | MNDR-E-MI-21461 |
| MNDR | hsa-miR-188-5p | Pituitary neoplasms | MNDR-E-MI-21462 |
| MNDR | hsa-miR-188-5p | Pancreatic cancer | MNDR-E-MI-21463 |
| MNDR | hsa-miR-188-5p | Melanoma | MNDR-E-MI-21464 |
| MNDR | hsa-miR-188-5p | Nephroblastoma | MNDR-E-MI-21465 |
| MNDR | hsa-miR-188-5p | Colon cancer | MNDR-E-MI-21466 |
| MNDR | hsa-miR-188-5p | Colon adenocarcinoma | MNDR-E-MI-21467 |
| MNDR | hsa-miR-188-5p | Familial ovarian cancer | MNDR-E-MI-21468 |
| MNDR | hsa-miR-188-5p | Carcinoma ductal breast | MNDR-E-MI-21469 |
| MNDR | hsa-miR-188-5p | Glioblastoma | MNDR-E-MI-21470 |
| MNDR | hsa-miR-188-5p | Glioma | MNDR-E-MI-21471 |
| MNDR | hsa-miR-188-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-21472 |
| MNDR | hsa-miR-188-5p | Osteosarcoma | MNDR-E-MI-21473 |
| MNDR | hsa-miR-188-5p | Breast carcinoma | MNDR-E-MI-21474 |
| MNDR | hsa-miR-188-5p | Meningioma | MNDR-E-MI-21475 |
| MNDR | hsa-miR-188-5p | Liver cancer | MNDR-E-MI-21476 |
| MNDR | hsa-miR-188-5p | Cervical adenocarcinoma | MNDR-E-MI-21477 |
| MNDR | hsa-miR-188-5p | Gastric adenocarcinoma | MNDR-E-MI-21478 |
| MNDR | hsa-miR-188-5p | Cervical squamous cell carcinoma | MNDR-E-MI-21479 |
| MNDR | hsa-miR-188-5p | Pituitary adenoma | MNDR-E-MI-21480 |
| MNDR | hsa-miR-188-5p | Lung squamous cell carcinoma | MNDR-E-MI-21481 |
| MNDR | hsa-miR-188-5p | Lung adenocarcinoma | MNDR-E-MI-21482 |
| MNDR | hsa-miR-188-5p | Thyroid carcinoma | MNDR-E-MI-21483 |
| MNDR | hsa-miR-188-5p | Ovarian carcinoma | MNDR-E-MI-21484 |
| MNDR | hsa-miR-188-5p | Bladder urothelial carcinoma | MNDR-E-MI-21485 |
| MNDR | hsa-miR-188-5p | Pancreatic adenocarcinoma | MNDR-E-MI-21486 |
| MNDR | hsa-miR-188-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-21487 |
| MNDR | hsa-miR-188-5p | Carcinoma renal cell | MNDR-E-MI-21488 |
| MNDR | hsa-miR-188-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-21489 |
| MNDR | hsa-miR-188-5p | Clear cell renal cell carcinoma | MNDR-E-MI-21490 |
| MNDR | hsa-miR-188-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-21491 |
| MNDR | hsa-miR-188-5p | Cholangiocarcinoma | MNDR-E-MI-21492 |
| MNDR | hsa-miR-188-5p | Esophageal cancer | MNDR-E-MI-21493 |
| MNDR | hsa-miR-188-5p | Oncocytoma | MNDR-E-MI-21494 |
| MNDR | hsa-miR-188-5p | Lung small cell carcinoma | MNDR-E-MI-21495 |
| MNDR | hsa-miR-188-5p | Breast invasive carcinoma | MNDR-E-MI-21496 |
| MNDR | hsa-miR-188-5p | Hepatocellular carcinoma | MNDR-E-MI-21497 |
| MNDR | hsa-miR-188-5p | Familiar ovarian carcinoma | MNDR-E-MI-21498 |
| MNDR | hsa-miR-188-5p | B-cell lymphoma | MNDR-E-MI-21499 |
| MNDR | hsa-miR-188-5p | Retinoblastoma | MNDR-E-MI-21500 |
| MNDR | hsa-miR-188-5p | Burkitt lymphoma | MNDR-E-MI-21501 |
| MNDR | hsa-miR-188-5p | Colorectal cancer | MNDR-E-MI-21502 |
| MNDR | hsa-miR-188-5p | Multiple myeloma | MNDR-E-MI-21503 |
| MNDR | hsa-miR-188-5p | Acute lymphocytic leukemia | MNDR-E-MI-21504 |
| MNDR | hsa-miR-188-5p | Nasopharyngeal cancer | MNDR-E-MI-21505 |
| MNDR | hsa-miR-188-5p | Breast cancer her3+ negative | MNDR-E-MI-21506 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | FGF5 | Homo sapiens | RR00564224 |
TOP